SHE:002793 Revenue

Luoxin Pharmaceuticals Group Stock had revenue of 594.52M CNY in the quarter ending June 30, 2025, with 4.21% growth. This brings the company's revenue in the last twelve months to 2.49B, up 2.96% year-over-year. In the year 2024, Luoxin Pharmaceuticals Group Stock had annual revenue of 2.65B with 11.99% growth.

Revenue (ttm)

2.49B

Revenue Growth

+2.96%

P/S Ratio

2.10

Revenue / Employee

779.06K

Employees

3,196

Market Cap

5.23B

Revenue Chart

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	2.65B	283.50M	11.99%
Dec 31, 2023	2.36B	-1.22B	-34.11%
Jan 1, 2023	3.59B	-2.89B	-44.62%
Jan 1, 2022	6.48B	381.70M	6.26%
Dec 31, 2020	6.10B	-1.49B	-19.67%
Dec 31, 2019	Upgrade Pro	Upgrade Pro	Upgrade Pro
Dec 31, 2018	Upgrade Pro	Upgrade Pro	Upgrade Pro
Dec 31, 2016	Upgrade Pro	Upgrade Pro	Upgrade Pro
Dec 31, 2015	Upgrade Pro	Upgrade Pro	Upgrade Pro
Dec 31, 2014	Upgrade Pro	Upgrade Pro	Upgrade Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name	Revenue
Jianmin Pharmaceutical Group	3.18B
Fuan Pharmaceutical (Group)	1.71B
Hunan Fangsheng Pharmaceutical	1.68B
Zhuhai Rundu Pharmaceutical	1.19B
Nanjing Hicin Pharmaceutical	615.39M
Zhongzhu Healthcare Holding Co.,Ltd	570.62M
Hubei Biocause Heilen Pharmaceutical	430.77M
Beijing Science Sun Pharmaceutical	402.23M

Revenue Rankings